HERC1 mutations in idiopathic intellectual disability.

Area of Science:

• Genetics
• Neuroscience
• Biochemistry

Background:

• HERC1 (HECT and RLD domain containing E3 ubiquitin protein ligase 1) is a ubiquitin ligase and a guanine nucleotide exchange factor.
• HERC1 negatively regulates the mTOR pathway and influences ARF and Rab GTPase activity.
• Biallelic mutations in HERC1 have been linked to a human phenotype characterized by overgrowth and intellectual disability.

Observation:

• This study details the clinical features of an additional patient with a novel homozygous mutation in HERC1.
• The patient presented with moderate to severe intellectual disability, hypotonia, macrocephaly, tall stature, and distinct facial features.
• Associated features included kyphoscoliosis, seizures, and potential autistic features.

Findings:

• Homozygous mutations in HERC1 result in a distinct neurodevelopmental disorder.
• Key clinical manifestations include intellectual disability, overgrowth (tall stature, macrocephaly), hypotonia, and specific facial dysmorphia.
• Neurological comorbidities such as seizures and behavioral issues like autistic features are frequently observed.

Implications:

• HERC1 mutations should be considered in the differential diagnosis of severe intellectual disability and behavioral problems.
• Genetic testing for HERC1 mutations is crucial, especially in patients negative for Fragile X and KANSL1 mutations.
• Further research into HERC1's role in neurodevelopment may reveal new therapeutic targets.